연구성과로 돌아가기
JCR 2022 저널 목록 (382 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomedical Journal | ELSEVIER | 2319-4170 | 2320-2890 | SCIE | MEDICINE, RESEARCH & EXPERIMENTAL | 2,788 | 5.5 | Q2 | 27.6 | 72.4 | 38/136 | 6.1 | Q1 | 5.4 | 3.2 | 0.92 | 54/190 | Q2 | 71.84 | 0.003 | 0.667 | 1.148 | Q2 | 89 | 61.8% | 3.8 | 8.8 | 55 | 98.8% | 2025-04-21 10:16:23 | 바로가기 |
| BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY | WILEY | 0007-1102 | 2044-8317 | SCIE | MATHEMATICS, INTERDISCIPLINARY APPLICATIONS | 2,759 | 2.6 | Q2 | 27.6 | 72.4 | 30/107 | 2.9 | Q2 | 2.5 | 0.3 | 0.85 | 35/134 | Q2 | 74.25 | 0.002 | 0.496 | 1.652 | Q1 | 28 | 100.0% | 13.7 | 12.7 | 28 | 17.1% | 2025-04-21 10:13:24 | 바로가기 |
| Cancer Biology & Medicine | CHINA ANTI-CANCER ASSOC | 2095-3941 | 2095-3941 | SCIE | MEDICINE, RESEARCH & EXPERIMENTAL | 3,145 | 5.5 | Q2 | 27.6 | 72.4 | 38/136 | 6.1 | Q1 | 5.3 | 0.8 | 0.88 | 60/190 | Q2 | 68.68 | 0.004 | 0.801 | 1.133 | Q2 | 43 | 58.1% | 3.8 | 5.0 | 25 | 92.8% | 2025-04-21 10:16:21 | 바로가기 |
| EUROPEAN ADDICTION RESEARCH | KARGER | 1022-6877 | 1421-9891 | SSCI | SUBSTANCE ABUSE | 1,600 | 3.9 | Q2 | 27.6 | 72.4 | 11/38 | 3.3 | Q2 | 3.7 | 0.7 | 0.98 | 13/54 | Q1 | 76.85 | 0.002 | 0.379 | 0.977 | Q3 | 36 | 97.2% | 7.3 | 6.8 | 35 | 38.1% | 2025-04-21 10:38:08 | 바로가기 |
| EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | WILEY | 0014-2972 | 1365-2362 | SCIE | MEDICINE, RESEARCH & EXPERIMENTAL | 9,025 | 5.5 | Q2 | 27.6 | 72.4 | 38/136 | 5.0 | Q2 | 5.3 | 1.1 | 0.99 | 46/190 | Q1 | 76.05 | 0.008 | 1.694 | 1.183 | Q2 | 153 | 78.4% | 7.6 | 5.5 | 120 | 16.8% | 2025-04-21 10:16:15 | 바로가기 |
| Expert Review of Neurotherapeutics | TAYLOR & FRANCIS LTD | 1473-7175 | 1744-8360 | SCIE | CLINICAL NEUROLOGY | 5,627 | 4.3 | Q2 | 27.6 | 72.4 | 59/212 | 4.4 | Q2 | 4.2 | 0.7 | 0.62 | 159/269 | Q3 | 41.08 | 0.005 | 0.996 | 1.081 | Q2 | 67 | 29.8% | 7.6 | 7.0 | 20 | 10.8% | 2025-04-21 09:39:42 | 바로가기 |
| Expert Review of Vaccines | TAYLOR & FRANCIS LTD | 1476-0584 | 1744-8395 | SCIE | IMMUNOLOGY | 6,396 | 6.2 | Q2 | 27.6 | 72.4 | 45/161 | 5.6 | Q2 | 6.0 | 2.1 | 0.67 | 89/177 | Q3 | 50.00 | 0.007 | 1.580 | 1.556 | Q2 | 125 | 46.4% | 5.9 | 4.5 | 58 | 33.5% | 2025-04-21 10:04:30 | 바로가기 |
| FlatChem | ELSEVIER | 2452-2627 | 2452-2627 | SCIE | CHEMISTRY, PHYSICAL | 1,567 | 6.2 | Q2 | 27.6 | 72.4 | 45/161 | 5.7 | Q2 | 5.8 | 1.5 | 0.81 | 58/172 | Q2 | 66.57 | 0.002 | 0.392 | 0.830 | Q2 | 110 | 96.4% | 2.2 | 5.3 | 106 | 6.1% | 2025-04-21 09:39:05 | 바로가기 |
| Infectious Diseases and Therapy | SPRINGER LONDON LTD | 2193-8229 | 2193-6382 | SCIE | INFECTIOUS DISEASES | 2,452 | 5.4 | Q2 | 27.6 | 72.4 | 27/96 | 5.1 | Q2 | 5.3 | 0.8 | 0.84 | 42/129 | Q2 | 67.83 | 0.005 | 1.077 | 1.408 | Q1 | 137 | 81.0% | 2.3 | 5.1 | 111 | 99.3% | 2025-04-21 10:05:03 | 바로가기 |
| INFORMATION SOCIETY | TAYLOR & FRANCIS INC | 0197-2243 | 1087-6537 | SSCI | COMMUNICATION | 1,578 | 3.5 | Q2 | 27.6 | 72.4 | 27/96 | 4.2 | Q2 | 3.5 | 0.3 | 1.01 | 58/219 | Q2 | 73.74 | 0.001 | 0.316 | 1.532 | Q1 | 25 | 100.0% | 12.0 | 7.9 | 25 | 25.0% | 2025-04-21 09:40:27 | 바로가기 |
| International Small Business Journal-Researching Entrepreneurship | SAGE PUBLICATIONS LTD | 0266-2426 | 1741-2870 | SSCI | BUSINESS | 5,069 | 7.1 | Q2 | 27.6 | 72.4 | 43/154 | 7.6 | Q2 | 6.5 | 0.8 | 1.27 | 60/306 | Q1 | 80.56 | 0.003 | 0.621 | 1.511 | Q2 | 43 | 97.7% | 8.0 | 9.5 | 42 | 35.6% | 2025-04-21 09:35:49 | 바로가기 |
| Journal of Alloys and Compounds | ELSEVIER SCIENCE SA | 0925-8388 | 1873-4669 | SCIE | CHEMISTRY, PHYSICAL | 198,756 | 6.2 | Q2 | 27.6 | 72.4 | 45/161 | 5.3 | Q2 | 5.3 | 1.7 | 1.20 | 37/172 | Q1 | 78.78 | 0.153 | 33.293 | 0.738 | Q2 | 4855 | 99.0% | 4.1 | 4.7 | 4805 | 4.7% | 2025-04-21 09:38:45 | 바로가기 |
| Journal of Clinical Sleep Medicine | AMER ACAD SLEEP MEDICINE | 1550-9389 | 1550-9397 | SCIE | CLINICAL NEUROLOGY | 11,563 | 4.3 | Q2 | 27.6 | 72.4 | 59/212 | 5.3 | Q1 | 4.0 | 1.2 | 1.15 | 54/269 | Q1 | 80.11 | 0.013 | 2.865 | 1.487 | Q1 | 263 | 91.6% | 6.1 | 8.9 | 241 | 0.1% | 2025-04-21 09:39:34 | 바로가기 |
| JOURNAL OF SUBSTANCE ABUSE TREATMENT | PERGAMON-ELSEVIER SCIENCE LTD | 0740-5472 | 1873-6483 | SSCI | SUBSTANCE ABUSE | 8,007 | 3.9 | Q2 | 27.6 | 72.4 | 11/38 | 3.9 | Q2 | 3.5 | 1.1 | 1.21 | 8/54 | Q1 | 86.11 | 0.012 | 2.532 | 1.452 | Q1 | 185 | 95.1% | 6.4 | 6.9 | 176 | 16.9% | 2025-04-21 10:38:05 | 바로가기 |
| JOURNAL OF THE MECHANICS AND PHYSICS OF SOLIDS | PERGAMON-ELSEVIER SCIENCE LTD | 0022-5096 | 1873-4782 | SCIE | PHYSICS, CONDENSED MATTER | 27,022 | 5.3 | Q2 | 27.6 | 72.4 | 19/67 | 5.9 | Q2 | 4.8 | 1.1 | 1.09 | 15/76 | Q1 | 80.92 | 0.018 | 3.820 | 1.489 | Q2 | 270 | 99.6% | 12.3 | 10.6 | 269 | 33.2% | 2025-04-21 10:25:59 | 바로가기 |
페이지 이동: